Schepers R H, Slagter A P, Kaanders J H A M, van den Hoogen F J A, Merkx M A W
Department of Oral and Maxillofacial Surgery, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
Int J Oral Maxillofac Surg. 2006 Sep;35(9):803-8. doi: 10.1016/j.ijom.2006.03.007. Epub 2006 May 11.
The purpose of this retrospective study was to evaluate the survival of dental implants placed during ablative surgery in the interforaminal region of the original edentulous mandible in patients with squamous cell carcinoma of the oral cavity in relation to postoperative radiotherapy. Forty-eight patients treated in 1996-2003 with surgery alone or in combination with postoperative radiotherapy were analysed. In all patients, 2 to 4 Brånemark Mk II/III 2-phase implants were placed during tumour resection. A total of 139 implants were placed of which 61 (21 patients) received postoperative radiotherapy: 60-68 Gy as a boost dose on the primary tumour site and 10-68 Gy on the symphyseal area. No difference was found in percentage of functional dentures on implants between the radiated and non-radiated groups. The success rate of osseointegration was 97% in the postoperative irradiated group and 100% in the non-irradiated group. The prosthetic success rate (75%) was lower because in 12 of the 48 patients (34 implants) a functional denture could not be fitted due to tumour recurrence or metastasis (7 patients, 22 implants) or for psychological reasons (4 patients, 12 implants), independent of whether radiotherapy was administered. Postoperative radiotherapy does not affect the osseointegration of dental implants placed during tumour ablation and the ultimate number of functional dentures. Primary implant placement in edentulous mandibles may have advantages over secondary implant placement in patients with oral squamous cell carcinoma.
本回顾性研究的目的是评估口腔鳞状细胞癌患者在原无牙下颌骨孔间区域进行消融手术时植入牙种植体的存活率与术后放疗的关系。分析了1996年至2003年接受单纯手术或联合术后放疗的48例患者。所有患者在肿瘤切除期间植入2至4枚Brånemark Mk II/III 2期种植体。共植入139枚种植体,其中61枚(21例患者)接受了术后放疗:原发肿瘤部位追加剂量60 - 68 Gy,耻骨联合区域剂量10 - 68 Gy。放疗组和未放疗组种植体上功能性假牙的百分比没有差异。术后放疗组的骨结合成功率为97%,未放疗组为100%。修复成功率(75%)较低,因为48例患者中有12例(34枚种植体)由于肿瘤复发或转移(7例患者,22枚种植体)或心理原因(4例患者,12枚种植体)无法安装功能性假牙,与是否进行放疗无关。术后放疗不影响肿瘤消融期间植入牙种植体的骨结合以及最终功能性假牙的数量。在无牙下颌骨中一期植入种植体可能比在口腔鳞状细胞癌患者中二期植入种植体更具优势。